Cargando…

Utility of telemedicine in pediatric rheumatology during the COVID-19 pandemic

BACKGROUND: During the COVID-19 pandemic, telemedicine has provided an alternative to in-person visits for patients practicing social distancing and undergoing quarantine. During this time, there has been a rapid expansion of telemedicine and its implementation in various clinical specialties and se...

Descripción completa

Detalles Bibliográficos
Autores principales: Perdue, Ashley, Mullett, Charles, Umer, Amna, Rosen, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481105/
https://www.ncbi.nlm.nih.gov/pubmed/34593000
http://dx.doi.org/10.1186/s12969-021-00624-z
_version_ 1784576610276474880
author Perdue, Ashley
Mullett, Charles
Umer, Amna
Rosen, Paul
author_facet Perdue, Ashley
Mullett, Charles
Umer, Amna
Rosen, Paul
author_sort Perdue, Ashley
collection PubMed
description BACKGROUND: During the COVID-19 pandemic, telemedicine has provided an alternative to in-person visits for patients practicing social distancing and undergoing quarantine. During this time, there has been a rapid expansion of telemedicine and its implementation in various clinical specialties and settings. In this observational study we aim to examine the utility of telemedicine in a pediatric rheumatology clinic, for 3 months during the COVID-19 pandemic. METHODS: A review of outpatient pediatric rheumatology telemedicine encounters were conducted from April–June 2020. Telemedicine visits (n = 75) were compared to patients seen in practice over the prior year in office-based visits (March 2019–March 2020) (n = 415). Patient characteristics, information on no-show visits, completed visits, new patient or follow-up status, and if new patients had received a visit within 2 weeks of calling to schedule an appointment were analyzed by chart review. An independent sample t-test and Chi Square statistic was used to determine statical significance between the two groups. A two-proportion z-test was used to compare visit metrics. RESULTS: The percentage of new patients utilizing telemedicine (60%) was lower and statistically significant compared to the percentage of new patient office visits (84%) the previous year (p < 0.0001). There was no change in no-show rate between groups and patient characteristics were similar. CONCLUSIONS: This study demonstrates a statistically significant decrease in new patient visits during the pandemic with telemedicine-only appointments compared to in-office visits over the previous year. This suggests a possible hesitation to seek care during this time. However, there was no significant difference among patient characteristics between telemedicine visits during the pandemic and during in-office visits in the previous year. In our experience, patient visits were able to be conducted via telemedicine with a limited physical exam using caregiver’s help during the pandemic. However, further studies will need to ascertain patient satisfaction and preference for telemedicine in the future.
format Online
Article
Text
id pubmed-8481105
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84811052021-09-30 Utility of telemedicine in pediatric rheumatology during the COVID-19 pandemic Perdue, Ashley Mullett, Charles Umer, Amna Rosen, Paul Pediatr Rheumatol Online J Research Article BACKGROUND: During the COVID-19 pandemic, telemedicine has provided an alternative to in-person visits for patients practicing social distancing and undergoing quarantine. During this time, there has been a rapid expansion of telemedicine and its implementation in various clinical specialties and settings. In this observational study we aim to examine the utility of telemedicine in a pediatric rheumatology clinic, for 3 months during the COVID-19 pandemic. METHODS: A review of outpatient pediatric rheumatology telemedicine encounters were conducted from April–June 2020. Telemedicine visits (n = 75) were compared to patients seen in practice over the prior year in office-based visits (March 2019–March 2020) (n = 415). Patient characteristics, information on no-show visits, completed visits, new patient or follow-up status, and if new patients had received a visit within 2 weeks of calling to schedule an appointment were analyzed by chart review. An independent sample t-test and Chi Square statistic was used to determine statical significance between the two groups. A two-proportion z-test was used to compare visit metrics. RESULTS: The percentage of new patients utilizing telemedicine (60%) was lower and statistically significant compared to the percentage of new patient office visits (84%) the previous year (p < 0.0001). There was no change in no-show rate between groups and patient characteristics were similar. CONCLUSIONS: This study demonstrates a statistically significant decrease in new patient visits during the pandemic with telemedicine-only appointments compared to in-office visits over the previous year. This suggests a possible hesitation to seek care during this time. However, there was no significant difference among patient characteristics between telemedicine visits during the pandemic and during in-office visits in the previous year. In our experience, patient visits were able to be conducted via telemedicine with a limited physical exam using caregiver’s help during the pandemic. However, further studies will need to ascertain patient satisfaction and preference for telemedicine in the future. BioMed Central 2021-09-30 /pmc/articles/PMC8481105/ /pubmed/34593000 http://dx.doi.org/10.1186/s12969-021-00624-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Perdue, Ashley
Mullett, Charles
Umer, Amna
Rosen, Paul
Utility of telemedicine in pediatric rheumatology during the COVID-19 pandemic
title Utility of telemedicine in pediatric rheumatology during the COVID-19 pandemic
title_full Utility of telemedicine in pediatric rheumatology during the COVID-19 pandemic
title_fullStr Utility of telemedicine in pediatric rheumatology during the COVID-19 pandemic
title_full_unstemmed Utility of telemedicine in pediatric rheumatology during the COVID-19 pandemic
title_short Utility of telemedicine in pediatric rheumatology during the COVID-19 pandemic
title_sort utility of telemedicine in pediatric rheumatology during the covid-19 pandemic
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481105/
https://www.ncbi.nlm.nih.gov/pubmed/34593000
http://dx.doi.org/10.1186/s12969-021-00624-z
work_keys_str_mv AT perdueashley utilityoftelemedicineinpediatricrheumatologyduringthecovid19pandemic
AT mullettcharles utilityoftelemedicineinpediatricrheumatologyduringthecovid19pandemic
AT umeramna utilityoftelemedicineinpediatricrheumatologyduringthecovid19pandemic
AT rosenpaul utilityoftelemedicineinpediatricrheumatologyduringthecovid19pandemic